Back to today’s briefing

Story perspectives

Revolutionizing Cancer Treatment: PDX Models and CRISPR Advances

6/11/2025

50 9

Summary

Story summary

Cancer continues to pose a significant threat worldwide, affecting millions each year. A recent review in *Genes & Diseases* champions patient-derived xenograft (PDX) models for drug development, as they closely replicate human tumors. While challenges such as high costs and tumor evolution persist, advancements like CRISPR and organoid co-cultures promise to revolutionize precision oncology.

1 of 1

Story summary

Cancer continues to pose a significant threat worldwide, affecting millions each year. A recent review in *Genes & Diseases* champions patient-derived xenograft (PDX) models for drug development, as they closely replicate human tumors. While challenges such as high costs and tumor evolution persist, advancements like CRISPR and organoid co-cultures promise to revolutionize precision oncology.